Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
UCLA, Los Angeles, California Mayo Clinic, Rochester, Minnesota Memorial Sloane Kettering Cancer Center, New York, New York Case Western, Cleveland, Ohio MD Anderson Cancer Center, Houston, Texas Canada
Princess Margaret Cancer Centre, Toronto, Ontario